An autoimmune disease refractory to immunosuppressive regimens: Celiac disease diagnosed long after liver transplantation
dc.contributor.author | Ecevit, Cigdem | |
dc.contributor.author | Karakoyun, Miray | |
dc.contributor.author | Unal, Fatih | |
dc.contributor.author | Yuksekkaya, Hasan A. | |
dc.contributor.author | Doganavsargil, Basak | |
dc.contributor.author | Yagci, Rasit V. | |
dc.contributor.author | Aydogdu, Sema | |
dc.date.accessioned | 2019-10-27T22:07:26Z | |
dc.date.available | 2019-10-27T22:07:26Z | |
dc.date.issued | 2013 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | CD is defined as T-lymphocyte-mediated gluten sensitivity. Although CD is known to affect the small intestine, it is nonetheless a multisystem disorder. Liver involvement in CD may vary from isolated hypertransaminasemia to cirrhosis. Because CD is an inappropriate immune response to gluten proteins, strict gluten-free diet is the principal therapy, along with management of liver dysfunction. In patients who fail to respond to a gluten-free diet, immunosuppressive drugs may improve intestinal inflammatory activity in untreated CD. The present case report is of a 25-yr-old woman with diarrhea lasting several weeks. The patient had received a liver transplant 13yr earlier, and presented with cryptogenic cirrhosis diagnosed as CD. This appears to be the first case of its kind in which a pediatric long-term liver transplant patient presents with diarrhea eventually diagnosed as CD whose diet included gluten, and who was treated by an immunosuppressive drug regimen. Because of the normalization of CD-related antibodies in the post-transplantation period without gluten restriction, CD should be part of a list of diagnostic possibilities in liver transplant patients presenting with diarrhea of unknown etiology. | en_US |
dc.identifier.doi | 10.1111/petr.12136 | en_US |
dc.identifier.endpage | E160 | en_US |
dc.identifier.issn | 1397-3142 | |
dc.identifier.issn | 1399-3046 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.pmid | 23962034 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | E156 | en_US |
dc.identifier.uri | https://doi.org/10.1111/petr.12136 | |
dc.identifier.uri | https://hdl.handle.net/11454/49013 | |
dc.identifier.volume | 17 | en_US |
dc.identifier.wos | WOS:000325369400002 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Pediatric Transplantation | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | celiac disease | en_US |
dc.subject | immunosuppressive therapy | en_US |
dc.subject | liver transplantation | en_US |
dc.title | An autoimmune disease refractory to immunosuppressive regimens: Celiac disease diagnosed long after liver transplantation | en_US |
dc.type | Article | en_US |